CN114989032B - 一种酰亚胺类衍生物的合成方法 - Google Patents

一种酰亚胺类衍生物的合成方法 Download PDF

Info

Publication number
CN114989032B
CN114989032B CN202210671658.XA CN202210671658A CN114989032B CN 114989032 B CN114989032 B CN 114989032B CN 202210671658 A CN202210671658 A CN 202210671658A CN 114989032 B CN114989032 B CN 114989032B
Authority
CN
China
Prior art keywords
carboxylic acid
ethyl acetate
petroleum ether
cdcl
mmol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202210671658.XA
Other languages
English (en)
Other versions
CN114989032A (zh
Inventor
宣俊
姚维忠
蔡宝贵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anhui University
Original Assignee
Anhui University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anhui University filed Critical Anhui University
Priority to CN202210671658.XA priority Critical patent/CN114989032B/zh
Publication of CN114989032A publication Critical patent/CN114989032A/zh
Application granted granted Critical
Publication of CN114989032B publication Critical patent/CN114989032B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/10—Preparation of carboxylic acid amides from compounds not provided for in groups C07C231/02 - C07C231/08
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C231/00—Preparation of carboxylic acid amides
    • C07C231/22—Separation; Purification; Stabilisation; Use of additives
    • C07C231/24—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/32—Separation; Purification; Stabilisation; Use of additives
    • C07C253/34—Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
    • C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
    • C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D319/20—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring with substituents attached to the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075—Esters with hydroxyalkyl compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

本发明公开了一种酰亚胺类衍生物的合成方法，在光照条件下，利用重氮化合物和羧酸在腈类溶剂中进行反应，重氮化合物首先在光照条件下脱去一分子氮气产生活性卡宾物种，此时腈类溶剂作为卡宾捕获试剂可产生腈叶立德中间体，被羧酸捕获之后再经过进一步的Mumm重排可获得目标酰亚胺类衍生物。本方法不需要任何催化剂以及添加剂，只需要可见光作为绿色能源进行驱动，反应条件温和，易于操作，并能通过流动光化学的方法进行大量合成。

Description

一种酰亚胺类衍生物的合成方法
技术领域
本发明属于有机合成领域，具体涉及一种酰亚胺类衍生物的合成方法。
背景技术
酰亚胺类衍生物是有机合成领域、制药领域、电镀领域、以及电化学领域等最常见和最基本的有机化合物之一。因此，高效构建酰亚胺类衍生物已成为有机和药物化学领域深入研究的课题之一。
由于酰亚胺类衍生物的应用非常广泛，因此有机合成化学家们也开发了许多合成酰亚胺类衍生物的方法。在过去几年中，通过重氮化合物与芳基偶氮盐在腈类溶剂中进行反应构建酰亚胺类衍生物引起了广大科研工作者的兴趣，然而这些反应往往需要金属催化剂的参与。因此，开发在无任何催化剂以及添加剂条件下构建酰亚胺类衍生物的方法也是一项挑战。
发明内容
本课题组通过研究发现，在蓝色LED灯的照射下，重氮化合物脱去一份子氮气产生的活性卡宾物种首先被腈类溶剂捕获产生腈叶立德中间体，被羧酸捕获之后再经过进一步的Mumm重排可获得目标酰亚胺类衍生物从而为酰亚胺类衍生物的合成提供了温和的反应途径。同时我们也尝试了使用绿色LED灯作为光源，结果表明反应速率会急速下降。
基于以上研究背景，本发明提供了一种酰亚胺类衍生物的合成方法，利用重氮化合物与羧酸化合物在腈类溶剂中进行反应，简便的制备了各种1,2,4-三氮唑衍生物。本方法不需要任何催化剂以及添加剂，只需要可见光作为绿色能源进行驱动。
本发明酰亚胺类衍生物的合成方法，将重氮化合物1、羧酸化合物2加入腈类溶剂中，在光照条件下进行反应，分离提纯后得到目标产物3。
合成路线如下所示：
重氮化合物1中的取代基EWG为酯基、酰胺基、三氟甲基、氰基、磷酸酯等。
羧酸化合物2中的取代基R1为烷基、芳基或杂芳基、杂环化合物等。
腈类溶剂中的取代基R2为加甲基、乙基、异丙基、叔丁基、环丁基、芳基或氘代甲基。
所述分离提纯是通过硅胶柱层析分离纯化的方式，洗脱液为石油醚和乙酸乙酯，体积比10:1-3:1。
相较于现有技术，本发明的有益效果体现在：
1、所使用的原料容易制备，并且部分重氮化合物、羧酸化合物和腈类溶剂可以商业购买。
2、无需使用任何催化剂以及添加剂，仅仅只需要普通蓝色LED灯进行光照。
3、反应条件温和，易于操作，并能通过流动光化学的方法进行大量合成。
4、氮气作为唯一副产物，符合绿色化学理念。
具体实施方式
下面结合具体实施例对本发明技术方案作进一步的详细说明。
实施例1：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,12.2mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝10:1]，即得到纯净的产物，无色油状，产率：87％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.76–7.69(m,2H),7.61–7.54(m,1H),7.51–7.45(m,2H),4.50(s,2H),4.21(q,J＝7.2Hz,2H),2.16(s,3H),1.28(t,J＝7.1Hz,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.4,173.2,168.7,135.4,132.6,128.9,128.4,61.6,47.3,26.2,14.1.
实施例2：
在10mL反应瓶中，加入重氮化合物(0.4mmol,26.8mg)、羧酸(0.1mmol,12.2mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝10:1]，即得到纯净的产物，无色油状，产率：88％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.72–7.62(m,3H),7.59–7.51(m,2H),4.58(s,2H),2.22(s,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝172.2,171.9,133.9,133.5,129.3,128.4,115.0,33.7,26.0.
实施例3：
在10mL反应瓶中，加入重氮化合物(0.4mmol,44.0mg)、羧酸(0.1mmol,12.2mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝10:1]，即得到纯净的产物，无色油状，产率：81％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.73–7.59(m,3H),7.52(t,J＝8.0Hz,2H),4.58(q,J＝8.7Hz,2H),2.04(s,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.3,171.7,134.7,133.5,129.2,128.8,45.0(t,J＝69.1Hz),25.9.
实施例4：
在10mL反应瓶中，加入重氮化合物(0.4mmol,60.0mg)、羧酸(0.1mmol,12.2mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝5:1]，即得到纯净的产物，无色油状，产率：71％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.70(d,J＝7.4Hz,2H),7.62–7.56(m,1H),7.49(t,J＝7.7Hz,2H),4.36(d,J＝11.3Hz,2H),3.76(d,J＝10.9Hz,6H),2.04(s,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.4,172.2,135.3,132.9,129.0,128.8,53.0(d,J＝5.9Hz),40.8,39.3,26.1.
实施例5：
在10mL反应瓶中，加入重氮化合物(0.4mmol,51.3mg)、羧酸(0.1mmol,12.2mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝10:1]，即得到纯净的产物，无色油状，产率：76％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.75–7.69(m,2H),7.60–7.54(m,1H),7.50–7.45(m,2H),4.50(s,2H),4.12(t,J＝6.7Hz,2H),2.16(s,3H),1.70–1.63(m,2H),0.93(t,J＝7.4Hz,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.4,173.2,168.8,135.4,132.6,128.9,128.5,47.3,26.3,21.9,10.2.
实施例6：
在10mL反应瓶中，加入重氮化合物(0.4mmol,51.3mg)、羧酸(0.1mmol,12.2mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝10:1]，即得到纯净的产物，无色油状，产率：80％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.76–7.69(m,2H),7.60–7.54(m,1H),7.50–7.44(m,2H),5.12–5.01(m,1H),4.46(s,2H),2.16(s,3H),1.25(d,J＝6.3Hz,6H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.4,173.2,168.2,135.4,132.5,128.9,128.4,69.4,47.6,26.2,21.7.
实施例7：
在10mL反应瓶中，加入重氮化合物(0.4mmol,56.9mg)、羧酸(0.1mmol,12.2mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝10:1]，即得到纯净的产物，无色油状，产率：71％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.74–7.69(m,2H),7.59–7.54(m,1H),7.49–7.44(m,2H),4.39(s,2H),2.18(s,3H),1.46(s,9H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.5,173.2,167.7,135.5,132.5,128.8,128.4,82.3,48.1,28.0,26.2.
实施例8：
在10mL反应瓶中，加入重氮化合物(0.4mmol,70.5mg)、羧酸(0.1mmol,12.2mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝10:1]，即得到纯净的产物，无色油状，产率：77％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.70–7.65(m,2H),7.57–7.52(m,1H),7.42(t,J＝7.7Hz,2H),7.37–7.31(m,5H),5.18(s,2H),4.55(s,2H),2.15(s,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.5,173.3,168.7,135.4,135.3,132.7,129.0,128.7,128.6,128.5,128.4,67.4,47.5,26.4.
实施例9：
在10mL反应瓶中，加入重氮化合物(0.4mmol,88.0mg)、羧酸(0.1mmol,12.2mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝10:1]，即得到纯净的产物，无色油状，产率：81％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.74–7.68(m,2H),7.59–7.53(m,1H),7.49–7.44(m,2H),4.38(s,2H),2.18(s,6H),2.11(d,J＝3.0Hz,6H),1.65(s,6H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.5,173.2,167.4,135.5,132.4,128.8,128.4,82.4,48.1,41.2,36.0,30.8,26.2.
实施例10：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,12.2mg)以及nBuCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝10:1]，即得到纯净的产物，无色油状，产率：80％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.75–7.68(m,2H),7.60–7.53(m,1H),7.47(t,J＝7.5Hz,2H),4.47(s,2H),4.25–4.17(m,2H),2.44–2.36(m,2H),1.61–1.52(m,2H),1.30–1.18(m,5H),0.81(t,J＝7.4Hz,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝176.8,173.6,168.9,135.7,132.6,128.5,61.6,47.6,38.2,27.6,22.2,13.7.
实施例11：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,12.2mg)以及iPrCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝10:1]，即得到纯净的产物，无色油状，产率：83％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.76–7.69(m,2H),7.60–7.54(m,1H),7.50–7.44(m,2H),4.46(d,J＝0.9Hz,2H),4.25–4.18(m,2H),2.89–2.76(m,1H),1.27(t,J＝7.2Hz,3H),1.09(d,J＝6.7Hz,6H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝181.6,173.5,168.7,135.6,132.6,128.9,128.5,61.5,47.8,36.0,19.6,14.11.
实施例12：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,12.2mg)以及cyclopropanecarbonitrile(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝10:1]，即得到纯净的产物，无色油状，产率：90％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.82–7.76(m,2H),7.59–7.51(m,1H),7.51–7.44(m,2H),4.61(s,2H),4.25–4.19(m,2H),1.42–1.35(m,1H),1.28(t,J＝7.2Hz,3H),1.09–1.03(m,2H),0.65–0.59(m,2H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝177.5,173.4,168.9,135.9,132.5,129.1,128.7,61.5,47.0,18.6,14.1,12.1.
实施例13：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,17.2mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝5:1]，即得到纯净的产物，无色油状，产率：70％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝8.27(s,1H),7.97–7.8(m,3H),7.79–7.74(m,1H),7.66–7.55(m,2H),4.56(s,2H),4.27–4.19(m,2H),2.17(s,3H),1.28(t,J＝7.2Hz,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.6,173.3,168.8,135.1,132.5,132.4,129.7,129.1,129.0,128.6,127.9,127.3,124.4,61.6,47.5,26.3,14.1.
实施例14：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,16.6mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝5:1]，即得到纯净的产物，无色油状，产率：74％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.38–7.33(m,1H),7.23(d,J＝1.7Hz,1H),6.87(d,J＝8.1Hz,1H),6.07(s,2H),4.49(s,2H),4.22(q,J＝7.1Hz,2H),2.14(s,3H),1.28(t,J＝7.1Hz,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.0,172.7,168.8,151.7,148.3,129.1,124.8,109.0,108.4,102.1,61.6,47.4,26.0,14.1.
实施例15：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,13.6mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝5:1]，即得到纯净的产物，无色油状，产率：97％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝7.35–7.17(m,5H),4.42(s,2H),4.22–4.14(m,2H),4.01(s,2H),2.39(s,3H),1.25(t,J＝7.2Hz,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.4,172.6,168.3,133.5,129.2,128.4,127.0,61.5,45.8,44.1,26.0,13.9.
实施例16：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,12.3mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝5:1]，即得到纯净的产物，无色油状，产率：72％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝8.62(d,J＝4.6Hz,1H),7.96–7.84(m,2H),7.50–7.44(m,1H),4.67(s,2H),4.22–4.15(m,2H),2.31(s,3H),1.26(t,J＝7.1Hz,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝173.7,170.8,168.8,152.1,148.5,137.5,126.5,125.0,61.4,47.0,26.4,14.1.
实施例17：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,17.2mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝5:1]，即得到纯净的产物，无色油状，产率：49％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝9.16(d,J＝2.2Hz,1H),8.56(d,J＝1.4Hz,1H),8.18(d,J＝8.6Hz,1H),7.93(d,J＝8.2Hz,1H),7.90–7.84(m,1H),7.70–7.63(m,1H),4.56(s,2H),4.27–4.21(m,2H),2.26(s,3H),1.29(t,J＝7.1Hz,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝172.7,171.5,168.5,149.4,148.6,137.1,132.1,129.6,128.9,128.3,128.0,126.6,61.9,47.5,26.2,14.1.
实施例18：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,17.5mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝5:1]，即得到纯净的产物，无色油状，产率：41％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝8.27–8.20(m,1H),7.88(s,1H),7.41–7.29(m,3H),4.26–4.19(m,2H),4.04(d,J＝5.1Hz,2H),3.86(s,3H),2.05(s,3H),1.29(t,J＝7.1Hz,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝170.2,170.1,169.9,137.3,136.3,126.9,122.9,122.2,121.8,109.8,106.3,61.6,41.5,33.5,22.9,14.1.
实施例19：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,11.3mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝5:1]，即得到纯净的产物，无色油状，产率：75％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝8.93(s,1H),8.55(s,1H),4.44(s,2H),4.29–4.22(m,2H),2.42(s,3H),1.31(t,J＝7.1Hz,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝172.2,168.6,163.5,160.6,148.7,117.6,62.1,47.4,25.5,14.1.
实施例20：
在10mL反应瓶中，加入重氮化合物(0.4mmol,45.6mg)、羧酸(0.1mmol,18.0mg)以及MeCN(1mL)于蓝光照射下进行反应，TLC(用薄层层析色谱法)检测至反应完全后减压除去有机溶剂，用硅胶柱层析分离纯化[V(石油醚)：V(乙酸乙酯)＝10:1-5:1，本实施例优选V(石油醚)：V(乙酸乙酯)＝5:1]，即得到纯净的产物，无色油状，产率：56％。
目标化合物经测试：
1H NMR(400MHz,CDCl3,300K):δ(ppm)＝6.97–6.92(m,1H),6.91–6.83(m,3H),5.58(t,J＝3.4Hz,1H),4.50–4.39(m,4H),4.25–4.18(m,2H),2.36(s,3H),1.27(t,J＝7.1Hz,3H).
13C NMR(100MHz,CDCl3,300K):δ(ppm)＝172.6,170.6,168.1,143.1,142.7,122.0,121.6,117.1,116.9,73.9,64.5,62.0,46.3,25.3,14.0.

Claims (2)

1.一种酰亚胺类衍生物的合成方法，其特征在于：
在光照条件下，利用重氮化合物1与羧酸化合物2在腈类溶剂中进行反应，重氮化合物脱去一份子氮气产生的活性卡宾物种首先被腈类溶剂捕获产生1,3-偶极子中间体，被羧酸捕获后随后经历一步Mumm重排即可获得目标产物——酰亚胺类衍生物；
合成路线如下所示：
重氮化合物1中的取代基EWG为酯基、酰胺基、三氟甲基、氰基或磷酸酯；
羧酸化合物2中的取代基R1为烷基、芳基或杂环化合物；
腈类溶剂中的取代基R2为甲基、乙基、异丙基、叔丁基、环丁基、芳基或氘代甲基。
2.根据权利要求1所述的合成方法，其特征在于：
反应结束后分离提纯获得目标产物；所述分离提纯是通过硅胶柱层析分离纯化的方式，洗脱液为石油醚和乙酸乙酯，体积比10:1-3:1。
CN202210671658.XA 2022-06-14 2022-06-14 一种酰亚胺类衍生物的合成方法 Active CN114989032B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202210671658.XA CN114989032B (zh) 2022-06-14 2022-06-14 一种酰亚胺类衍生物的合成方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210671658.XA CN114989032B (zh) 2022-06-14 2022-06-14 一种酰亚胺类衍生物的合成方法

Publications (2)

Publication Number Publication Date
CN114989032A CN114989032A (zh) 2022-09-02
CN114989032B true CN114989032B (zh) 2024-04-12

Family

ID=83035410

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202210671658.XA Active CN114989032B (zh) 2022-06-14 2022-06-14 一种酰亚胺类衍生物的合成方法

Country Status (1)

Country Link
CN (1) CN114989032B (zh)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105294476A (zh) * 2015-11-11 2016-02-03 上海大学 2-酰氧基丙烯酰胺类化合物及其合成方法
CN111423336A (zh) * 2020-05-07 2020-07-17 江西省科学院应用物理研究所 一种直接合成n3f甲基羰基酰胺及其衍生物的方法
WO2021153720A1 (ja) * 2020-01-31 2021-08-05 クミアイ化学工業株式会社 ３－アルコキシ安息香酸アミド誘導体及び有害生物防除剤
CN114456121A (zh) * 2022-02-24 2022-05-10 安徽大学 一种1,2,4-三氮唑衍生物的合成方法

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105294476A (zh) * 2015-11-11 2016-02-03 上海大学 2-酰氧基丙烯酰胺类化合物及其合成方法
WO2021153720A1 (ja) * 2020-01-31 2021-08-05 クミアイ化学工業株式会社 ３－アルコキシ安息香酸アミド誘導体及び有害生物防除剤
CN111423336A (zh) * 2020-05-07 2020-07-17 江西省科学院应用物理研究所 一种直接合成n3f甲基羰基酰胺及其衍生物的方法
CN114456121A (zh) * 2022-02-24 2022-05-10 安徽大学 一种1,2,4-三氮唑衍生物的合成方法

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
In situ generation of nitrilium from nitrile ylide and the subsequent Mumm rearrangement: coppercatalyzed synthesis of unsymmetrical diacylglycine esters;Jijun Chen等;《Org. Biomol. Chem.》;第14卷;第10723-10732页 *
Late-Stage Transformation of Carboxylic Acids to N-Trifluoroethylimides with Trifluoromethyl Diazomethane;Xiao-Feng Qiu等;《Synthesis 》;20201217;第53卷;第961-970页 *
Visible-Light-Induced Imide Synthesis through a Nitrile Ylide Formation/Trapping Cascade;Bao-Gui Cai等;《Org. Lett.》;第24卷;第6647-6652页 *
酰胺类化合物合成的最新研究进展;董 浩等;《有机化学》;第37卷;第263-283页 *

Also Published As

Publication number Publication date
CN114989032A (zh) 2022-09-02

Similar Documents

Publication Publication Date Title
CN114456121B (zh) 一种1,2,4-三氮唑衍生物的合成方法
CN114524701B (zh) 一种n-n轴手性吡咯衍生物及其合成方法
EP3936511A1 (en) Ruthenium complexes, their optically pure enantiomers and uses thereof
CN111848675B (zh) 四氢喹啉骨架手性膦-氮配体及其制备方法和应用
CN114989032B (zh) 一种酰亚胺类衍生物的合成方法
CN114835652B (zh) 一种光催化条件下合成亚胺基苯并三唑类化合物的方法
CN115108937B (zh) 含三级立体中心的α-叠氮酮的合成方法
CN112279765B (zh) 一种手性α-氟代酮化合物的制备方法
CN114456112A (zh) 一种苯蒽啶衍生物的合成方法
CN112778317B (zh) 一种[1,2,4]三氮唑并[1,5-a]嘧啶类化合物的合成方法
CN111187176B (zh) 一种铜盐催化的制备n-乙烯基酰胺类化合物的方法
CN114933570B (zh) 一种铜催化的1,2,4-三氮唑衍生物的合成方法
CN113754604B (zh) 一类含氮手性配体及其在硫醚的不对称氧化反应中的应用
CN113444040A (zh) 一种可见光驱动下合成手性α-非天然氨基酸衍生物的方法
CN114524753B (zh) 一种多取代异羟肟酸衍生物的合成方法
CN86108424A (zh) 硝噻烯啶的合成方法
JP3345637B2 (ja) ヒドロキシ化合物の製造方法及びその製造用触媒
CN115651020A (zh) 一种可见光诱导缺电子不饱和烃化合物与二芳基乙氧基膦反应合成氧化膦的方法
CN117185925B (zh) 一种多取代芳基羧酸酯化合物的制备方法
Achmatowicz et al. The synthesis of l-proline derived hexaazamacrocyclic ligands of C3 symmetry via intramolecular methyl ester aminolysis
CN116768904A (zh) 一种手性四氢吲哚并咔唑化合物及其合成方法
CN107641085B (zh) 一种二苯烯酮及其衍生物的合成方法
KR0140323B1 (ko) 광활성α-아미노산의 제조방법
CN116535363A (zh) 碘叶立德参与的三组分环加成构建异恶唑烷衍生物的合成方法
CN114874109A (zh) 一种新型α-氰基-β-氨基丙烯酸酯类化合物及其合成方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant